144 related articles for article (PubMed ID: 11503011)
1. Influence of the variable number of tandem repeats located in the promoter region of the thiopurine methyltransferase gene on enzymatic activity.
Alves S; Amorim A; Ferreira F; Prata MJ
Clin Pharmacol Ther; 2001 Aug; 70(2):165-74. PubMed ID: 11503011
[TBL] [Abstract][Full Text] [Related]
2. Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis.
Yan L; Zhang S; Eiff B; Szumlanski CL; Powers M; O'Brien JF; Weinshilboum RM
Clin Pharmacol Ther; 2000 Aug; 68(2):210-9. PubMed ID: 10976552
[TBL] [Abstract][Full Text] [Related]
3. Novel motif of variable number of tandem repeats in TPMT promoter region and evolutionary association of variable number of tandem repeats with TPMT*3 alleles.
Urbančič D; Šmid A; Stocco G; Decorti G; Mlinarič-Raščan I; Karas Kuželički N
Pharmacogenomics; 2018 Nov; 19(17):1311-1322. PubMed ID: 30345902
[TBL] [Abstract][Full Text] [Related]
4. Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and Caucasians.
Marinaki AM; Arenas M; Khan ZH; Lewis CM; Shobowale-Bakre el-M; Escuredo E; Fairbanks LD; Mayberry JF; Wicks AC; Ansari A; Sanderson J; Duley JA
Pharmacogenetics; 2003 Feb; 13(2):97-105. PubMed ID: 12563179
[TBL] [Abstract][Full Text] [Related]
5. Evolution of a VNTR located within the promoter region of the thiopurine methyltransferase gene: inferences from population and sequence data.
Alves S; Amorim A; Prata MJ
Hum Genet; 2002 Aug; 111(2):172-8. PubMed ID: 12189491
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of the role of the TPMT gene promoter VNTR polymorphism in TPMT gene transcription.
Zukic B; Radmilovic M; Stojiljkovic M; Tosic N; Pourfarzad F; Dokmanovic L; Janic D; Colovic N; Philipsen S; Patrinos GP; Pavlovic S
Pharmacogenomics; 2010 Apr; 11(4):547-57. PubMed ID: 20350137
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter.
Spire-Vayron de la Moureyre C; Debuysère H; Fazio F; Sergent E; Bernard C; Sabbagh N; Marez D; Lo Guidice JM; D'halluin JC; Broly F
Pharmacogenetics; 1999 Apr; 9(2):189-98. PubMed ID: 10376766
[TBL] [Abstract][Full Text] [Related]
8. Genetic determinants of the pre- and post-azathioprine therapy thiopurine methyltransferase activity phenotype.
Arenas M; Duley JA; Ansari A; Shobowale-Bakre EA; Fairbanks L; Soon SY; Sanderson J; Marinaki AM
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1403-5. PubMed ID: 15571267
[TBL] [Abstract][Full Text] [Related]
9. Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population.
Spire-Vayron de la Moureyre C; Debuysere H; Mastain B; Vinner E; Marez D; Lo Guidice JM; Chevalier D; Brique S; Motte K; Colombel JF; Turck D; Noel C; Flipo RM; Pol A; Lhermitte M; Lafitte JJ; Libersa C; Broly F
Br J Pharmacol; 1998 Oct; 125(4):879-87. PubMed ID: 9831928
[TBL] [Abstract][Full Text] [Related]
10. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.
Collie-Duguid ES; Pritchard SC; Powrie RH; Sludden J; Collier DA; Li T; McLeod HL
Pharmacogenetics; 1999 Feb; 9(1):37-42. PubMed ID: 10208641
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants.
Schaeffeler E; Fischer C; Brockmeier D; Wernet D; Moerike K; Eichelbaum M; Zanger UM; Schwab M
Pharmacogenetics; 2004 Jul; 14(7):407-17. PubMed ID: 15226673
[TBL] [Abstract][Full Text] [Related]
12. Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age.
Ganiere-Monteil C; Medard Y; Lejus C; Bruneau B; Pineau A; Fenneteau O; Bourin M; Jacqz-Aigrain E
Eur J Clin Pharmacol; 2004 Apr; 60(2):89-96. PubMed ID: 15022030
[TBL] [Abstract][Full Text] [Related]
13. [Frequency of thiopurine S-methyltransferase alleles in different ethnic groups living in Spain].
Corominas H; Domènech M; del Río E; Gich I; Domingo P; Baiget M
Med Clin (Barc); 2006 Mar; 126(11):410-2. PubMed ID: 16595084
[TBL] [Abstract][Full Text] [Related]
14. Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals.
McLeod HL; Pritchard SC; Githang'a J; Indalo A; Ameyaw MM; Powrie RH; Booth L; Collie-Duguid ES
Pharmacogenetics; 1999 Dec; 9(6):773-6. PubMed ID: 10634140
[TBL] [Abstract][Full Text] [Related]
15. 6-mercaptopurine influences TPMT gene transcription in a TPMT gene promoter variable number of tandem repeats-dependent manner.
Kotur N; Stankovic B; Kassela K; Georgitsi M; Vicha A; Leontari I; Dokmanovic L; Janic D; Krstovski N; Klaassen K; Radmilovic M; Stojiljkovic M; Nikcevic G; Simeonidis A; Sivolapenko G; Pavlovic S; Patrinos GP; Zukic B
Pharmacogenomics; 2012 Feb; 13(3):283-95. PubMed ID: 22304581
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population.
Hakooz N; Arafat T; Payne D; Ollier W; Pushpakom S; Andrews J; Newman W
Eur J Clin Pharmacol; 2010 Oct; 66(10):999-1003. PubMed ID: 20521035
[TBL] [Abstract][Full Text] [Related]
17. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms.
Otterness D; Szumlanski C; Lennard L; Klemetsdal B; Aarbakke J; Park-Hah JO; Iven H; Schmiegelow K; Branum E; O'Brien J; Weinshilboum R
Clin Pharmacol Ther; 1997 Jul; 62(1):60-73. PubMed ID: 9246020
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the pharmacogenomics of thiopurine methyltransferase.
Coulthard SA; Hall AG
Pharmacogenomics J; 2001; 1(4):254-61. PubMed ID: 11908768
[TBL] [Abstract][Full Text] [Related]
19. TPMT gene expression is increased during maintenance therapy in childhood acute lymphoblastic leukemia patients in a TPMT gene promoter variable number of tandem repeat-dependent manner.
Kotur N; Dokmanovic L; Janic D; Stankovic B; Krstovski N; Tosic N; Katsila T; Patrinos GP; Zukic B; Pavlovic S
Pharmacogenomics; 2015; 16(15):1701-12. PubMed ID: 26411491
[TBL] [Abstract][Full Text] [Related]
20. Association between TPMT*3C and decreased thiopurine S-methyltransferase activity in patients with neuromyelitis optica spectrum disorders in China.
Gong X; Mei S; Li X; Li X; Zhou H; Liu Y; Zhou A; Yang L; Zhao Z; Zhang X
Int J Neurosci; 2018 Jun; 128(6):549-553. PubMed ID: 29191122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
